Localized prostate cancer
Conditions
Interventions
Sponsors
Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1) Histologically confirmed primary prostate adenocarcinoma 2) Clinical stage of T1b, T1c, T2a, T2b, T2c, T3a or T3b and N0 M0, in accordance with UICC 7th (2009) 3) ECOG Performance status is 0, 1 or 2 4) Twenty years or older of the age at registration 5) Untreated patient for prostate cancer, excluding neoadjuvant endocrine therapy 6) Patients are informed for diagnosis of prostate cancer and independently agree with this study on carbon-ion radiotherapy
Exclusion criteria
Exclusion criteria: 1) Patient with past history of radiotherapy for the targeted lesion 2) Patient with active double cancer 3) Patient with hormone-resistant prostate cancer 4) Patients with active and intractable infection in the targeted lesion 5) Patient with metal devices in the lesion 6) Other medical or psychological condition which is unsuitable for carbon-ion therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Biochemical progression-free survival at 5 years | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Overall survival, Disease-specific survival 2) Local recurrence-free survival 3) Early and late-phase adverse event rate | — |
Countries
Japan
Contacts
Public ContactHiroyuki Katoh
Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization Ion-beam Radiation Oncology Center
Outcome results
None listed